PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 29(4): 377-383
2009
© 2009 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floré, K. M.J.
Right arrow Articles by Delanghe, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floré, K. M.J.
Right arrow Articles by Delanghe, J. R.

INVITED REVIEWS

ANALYTICAL INTERFERENCES IN POINT-OF-CARE TESTING GLUCOMETERS BY ICODEXTRIN AND ITS METABOLITES: AN OVERVIEW

Katelijne M.J. Floré and Joris R. Delanghe

Department of Clinical Chemistry, University Hospital Ghent, Belgium

Correspondence to: J.R. Delanghe, Laboratory of Clinical Chemistry, Ghent University Hospital (2P8), De Pintelaan 185, B-9000 Ghent, Belgium. Joris.Delanghe{at}ugent.be

Current point-of-care testing (POCT) glucometers are based on various test principles. Two major method groups dominate the market: glucose oxidase-based systems and glucose dehydrogenase-based systems using pyrroloquinoline quinone (GDH-PQQ) as a cofactor. The GDH-PQQ-based glucometers are replacing the older glucose oxidase-based systems because of their lower sensitivity for oxygen. On the other hand, the GDH-PQQ test method results in falsely elevated blood glucose levels in peritoneal dialysis patients receiving solutions containing icodextrin (e.g., Extraneal; Baxter, Brussels, Belgium). Icodextrin is metabolized in the systemic circulation into different glucose polymers, but mainly maltose, which interferes with the GDH-PQQ-based method. Clinicians should be aware of this analytical interference. The POCT glucometers based on the GDH-PQQ method should preferably not be used in this high-risk population and POCT glucose results inconsistent with clinical suspicion of hypoglycemic coma should be retested with another testing system.

KEY WORDS: Icodextrin; hyperglycemia; point-of-care testing; maltose; GDH-PQQ.

Received 5 June 2008; accepted 27 January 2009.




This article has been cited by other articles:


Home page
Clin. DiabetesHome page
D. A. Price
Case Study: Recurrent Diabetic Ketoacidosis Resulting From Spurious Hypoglycemia: A Deleterious Consequence of Inadequate Detection of Partial Strip Filling by a Glucose Monitoring System
Clin. Diabetes, September 1, 2009; 27(4): 164 - 166.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2009 by Multimed Inc.